Background: Special low protein foods (SLPF) are essential in the nutritional management of patients with phenylketonuria (PKU). The study objectives were to: 1) identify the number of SLPF available for use in eight European countries and Turkey and 2) analyse the nutritional composition of SLPF available in one of these countries.
Background
Early diagnosis and treatment of patients with phenylketonuria (PKU) prevents major neuro-cognitive deficits [1] . This is mainly achieved through the prescription of a phenylalanine (Phe) restrictive diet, consisting of natural protein and Phe restriction, together with L-amino acids supplements and special low protein foods (SLPF) [2] ; the latter also used in other inborn errors of amino acid metabolism. The function of SLPF in the PKU diet is to provide energy and variety in the diet [2] . In PKU much emphasis has been placed on the role and dose of L-amino acids but little attention is given to the nutritional or energy profile of SLPF [3] . It is estimated that the patient's SLPF intake will depend on disorder severity, providing around 50 % of the total energy intake in the most severe forms of the disorder. Milder phenotypes, with a higher natural protein tolerance are likely to be less dependent on their use [3] .
SLPF have a low protein and Phe content but their micronutrient composition is unclear. In a normal diet, healthy energy food sources commonly provide other macro and micronutrients. In direct contrast, SLPF micronutrient fortification is uncommon and it is assumed that the majority of vitamins and minerals are provided from L-amino acids supplemented with micronutrients [4, 5] .
SLPF are regulated by the European legislation 'Foods for Special Medical Purposes' (Commission Directive 1999/21/EC of 25 March 1999; amended in Directive 2006/141/EC). This Directive sets out rules for the composition and labeling of foods that are specifically formulated, processed and intended for the dietary management of diseases, disorders or medical conditions of individuals who are being treated under medical supervision. The nutritional substances that may be used in the manufacture of foods for special medical purposes are also outlined in legislation: Commission Regulation (EC) No 953/2009 [6] . In addition, all Foods for Special Medical Purposes have to follow the European Food Information to Consumers Regulation No 1169/2011 and Regulation No 609/2013 which is only just being enforced in many countries. Manufacturers must provide information concerning the energy value and principal nutrients contained in such foods but only have to declare the vitamins and/or minerals if they are present in "significant amounts".
The objectives of this study were to identify the number of SLPF accessible for use in eight European countries and Turkey and to study the differences in the nutritional composition of SLPF available in one country (Portugal).
Methods
In July 2014, comprehensive nutritional composition data of SLPF suitable for PKU and available in Portugal was collected from dietary companies or from SLPF packaging labels. Excel product nutritional composition databases with the numbers and types of SLPF were created.
Products were organized in sub-groups: baby cereals, bread, breakfast cereals, cakes/mix cakes/pancake mix, chocolate/energy bars/jelly, cookies, flour, ice cream, milk replacers, pasta, rice and savoury foods. Nutritional composition was expressed in weight of product per 100 g or 100 mL. Vitamin and mineral profiles were compared with regular foods, matched for food type. Their nutritional composition was obtained from the Portuguese Food Composition Table (available at www.insa.pt) (exception was the micronutrient composition of regular baby cereals which was collected from respective food companies).
Participants from the European Nutritionist Expert Panel on PKU (ENEP) [a group of dietitians/medical doctors from PKU centers in Europe (Portugal, Spain, Belgium, Italy, Germany, Netherlands, UK, Denmark)
and Turkey] were invited to provide a list of SLPF available in their countries.
Results

Number of SLPF available in Europe and Turkey
In Italy there were over twice as many SLPF (n = 256) available compared with other countries, although in 4 countries (Spain, Netherlands, Turkey and Denmark) ( Table 1 ) the exact number of products available was unknown. Portugal had the least number of SLPF (n = 73) ( Table 1 ).
Nutritional composition of Portuguese SLPF
All Portuguese SLPF contained a mean Phe content of less than 50 mg/100 g [mean 21 mg (6 mg in milk replacers; 48 mg in baby cereals)], which is an acceptable level for a SLPF for PKU (Table 2) . Energy content varied widely between different SLPF sub-groups ( Table 2 ). The majority of SLPF sub-groups (with the exception of milk replacers) contained energy content ranging from 305 to 478 Kcal/100 g of product. Milk replacers had a mean energy content of 99 kcal/ 200 mL, whereas cookies contained a mean energy content of 51 kcal per 11 g unit. For 14 different cookies available in Portugal, the energy content varied between 23 and 96 kcal per unit. The SLPF energy content was predominantly from carbohydrate (CHO) and fat sources. SLPF with higher fat content had the highest energy content (Table 2) .
Within the SLPF sub-group of bread, the mean fat content was 5.8 g/100 g with two products containing almost 10 g/100 g, which is in contrast with the content usually found in regular bread [1.6 g/100 g (Table 3) ]. The energy contribution from CHO was also considerably higher. The CHO content of SLPF cookies was higher compared with regular cookies (Table 3) .
Information regarding age suitability of SLPF was not available on packaging for all products, although the majority contained this information. In general, SLPF food labels provided unclear information about fat and CHO quality/sources. The micronutrient composition of SLPF was lower compared with regular-matched foods in terms of vitamin and mineral profiles (Tables 4 and 5) . Considering all the 73 Portuguese SLPF analysed, 50 (69 %) of them stated only the mineral content on the label, 16 (22 %) of them gave no information about the vitamin and mineral profile and just 7 (10 %) products PT = Portugal; SP = Spain; BE = Belgium; IT = Italy; GER = Germany; NL = Netherlands; TK = Turkey; UK = United Kingdom; DK = Denmark; SLPF = Special low protein foods; NI = no information described the presence of vitamin and minerals on the label. In 7 of 12 SLPF sub-groups (58 %) the presence of any vitamin was not labelled on the packaging. For minerals, labelling was more common and in 8 of the 12 SLPF sub-groups (67 %), 100 % of the food items identified minerals on the food labelling.
Discussion
In PKU, a varying choice and availability of SLPF may disadvantage some European patients in their ability to achieve acceptable metabolic control. It was clear from this study, that there was no uniform availability of SLPF in eight European countries and Turkey, and in some countries there was limited knowledge and central
'control' about the range and type of products available. Different government policies and reimbursement strategies clearly contribute to this disparity [7] [8] [9] . A higher availability of SLPF is considered a pivotal part of a Phe-restricted diet. While their ingestion satisfies energy needs, they also help support "free" amino acids anabolism, improve dietary adherence and thereby help maintain blood Phe control within target ranges [4] . More investigation is needed in order to understand if availability of a higher and wider range of SLPF optimizes dietary adherence and contributes to improved nutritional status [10] .
The energy content of all SLPF is important and clearly justifies special attention when prescribing to patients in different clinical situations. In our opinion, the results presented here clearly justify improved labelling that would lead to better food choices. Considering the recent interest of nutritional status in the PKU management, other aspects of nutrition should be considered beyond blood Phe control [11] . Although similar to the general population, overweight is a concern in PKU, especially in older females [3] with poor Phe control. Dietary intake also clearly influences cardiometabolic markers and more detailed research is needed to understand if differences found between patients and controls have some origin in different dietary patterns [12] . When lipid and CHO compositions were compared with regular foods, we found higher contributions in 58 and 92 % of SLPF subgroups, respectively. These data, together with the fact that in 75 % of the SLPF sub-groups the energy content was higher than in regular foods, underlines the need for careful nutritional prescription and monitoring.
Another common feature of SLPF is lack of label micronutrient information when compared with regular matched-foods. Although micronutrients are mainly consumed through L-amino acid supplements [13, 14] , it is important that the nutritional profile is fully identified on the label. Also SLPF should contain a warning indicating that their nutritional profile does not replicate regular foods because patients, caregivers and health professionals may assume they provide other nutrients other than energy. At present, there are no detailed studies outlining their full nutritional contribution to a low Phe diet.
PKU is a chronic disorder and regular nutritional education is required [15] . It is essential that health professionals provide guidance on the amount of SLPF that should be prescribed in different clinical situations in PKU (e.g. children, pregnancy, overweight/obesity, with and without Sapropterin treatment). In order to optimize dietary prescription and to prevent nutritional status imbalances like overweight/obesity, the Portuguese PKU center adopted a color system in order to categorize SLPF, based on its nutritional profile. This analogy with the traffic light colors has been adopted on 
Conclusions
The difference found in the SLPF availability within Europe and Turkey is relevant and may contribute to difference in patient ability to maintain acceptable metabolic control across Europe. It is important that industry ensure a high quality of SLPF in respect to taste, acceptability and appearance to help improve patient adherence with diet therapy. However, it is also important that manufacturers increase the detail about nutritional composition and product labelling, although the European Food Information to Consumers Regulation No 1169/2011 should help improve the quality of information provided in the future. A careful analysis of nutritional profile of all products is desirable in order to better match the nutrient needs of each patient. 
